Enrico Barichello
Product Manager, Syringe Platform

Stevanato Group

Is this your profile?

About

Enrico Barichello, Product Manager, Syringe Platform, Stevanato Group, holds a Master’s degree in Industrial Engineering from the University of Padua. Since joining Stevanato Group in 2017, Mr Barichello has worked closely with cross-functional teams to define and execute the roadmap for new products, including the Alba® platform. Since 2023, he has been driving innovation and growth across Stevanato Group’s syringe portfolio.

Contributions

PREFILLED SYRINGES

PROVING THE DESIGN SPACE: ADVANCING THE DEVELOPMENT OF SYRINGE-DEVICE COMBINATIONS

Enrico Barichello and Courtney Nicholas Sutton the innovative combination of the Molly^® autoinjector with Alba^® and Nexa^® prefilled syringes, which addresses the need to streamline device approval by establishing comprehensive compatibility testing, collaboration between suppliers and validated solutions for drug delivery.

More contributions

TWO INTO ONE: SOLVING COMPLEX DRUG DELIVERY PROBLEMS WITH DUAL-CHAMBER CONTAINMENT SOLUTIONS

Enrico Barichello and Valerio Ravazzolo describe how dual-chamber solutions ensure isolation, integrity and safety for managing lyophilised and liquid drugs. With innovative and customisable designs, these technologies improve drug delivery, reduce contamination risks and simplify complex therapies, addressing the evolving needs of both pharmaceutical industry and patients.

PROTECTION AND PRODUCTION: OPTIMISING PRIMARY PACKAGING SOLUTIONS FOR mRNA THERAPIES

Enrico Barichello and Riccardo Prete discuss the impact that mRNA-based therapies are having on the modern pharmaceutical market and how these delicate therapies require careful handling, with a particular focus on how Stevanato’s portfolio of primary packaging products can be highly beneficial when bringing these critical medicines to market.

CONTAINER SELECTION FOR A HIGHLY SENSITIVE DRUG PRODUCT: A SUCCESS STORY

Enrico Barichello discusses Stevanato Group’s collaboration with a leading pharmaceutical company to identify a suitable container for a high-concentration monoclonal antibody. The partnership addressed key challenges and contributed to maintaining the drug’s stability and integrity throughout its lifecycle.

A NEW DIMENSION: BALANCING BIOLOGIC LIMITATIONS AND PATIENT PERCEPTIONS FOR AN ENHANCED INJECTION EXPERIENCE

Enrico Barichello and Carlo Valbonesi discuss the need to harmonise the formulation parameters with patient convenience and comfort for injections, and demonstrate how Stevanato Group has solved this issue through innovation in injector components.

INDUSTRIALISATION

BIOLOGIC INTEGRITY: MEASURING AND MANAGING THE HIDDEN LEACHABLES RISK FROM PFS ADHESIVE

Enrico Barichello considers the often-overlooked influence of adhesive in the assembly of prefilled syringes and how the hidden risks can be managed and overcome.

PREFILLED SYRINGES

REALISING REDUCTIONS IN DEAD VOLUMES WITHIN PREFILLED SYRINGES: A MANUFACTURER’S PERSPECTIVE

Enrico Barichello considers the benefits of prefilled syringes, including cost and waste reduction, and looks at the impact and challenges of dead volume within the syringe.

HOW TO ENSURE THE FUTURE DEMAND FOR BIOLOGICS CAN STILL BE DELIVERED BY INJECTABLES

Anthony Vico and Enrico Barichello discuss the demands that high-viscosity biologic formulations place on prefilled syringes, and how pharmaceutical companies can make the most of this growing market segment to deliver improved quality of life for patients.

Top